Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration

Area of Science:

• Molecular biology
• Cell biology
• Biochemistry

Background:

• Protein tyrosine phosphatases (PTP1B and TC-PTP) traditionally exhibit anti-oncogenic functions by down-regulating tyrosine kinase receptors.
• Recent studies suggest PTP1B positively influences breast cancer cell oncogenicity via the ERK pathway.
• The specific roles of PTP1B and TC-PTP in IGF-2-mediated effects on breast cancer cells remain incompletely understood.

Purpose of the Study:

• To investigate the roles of PTP1B and TC-PTP in insulin-like growth factor 2 (IGF-2)-induced growth, survival, and migration of MCF-7 breast cancer cells.
• To elucidate the involvement of the ERK pathway in these processes.

Main Methods:

• Small interfering RNA (siRNA) was employed to reduce the expression levels of PTP1B and TC-PTP.
• Cell growth, survival (under 4-OH Tamoxifen treatment), and migration assays were performed.
• ERK phosphorylation levels were assessed to evaluate pathway activation.

Main Results:

• Reduced expression of PTP1B and TC-PTP significantly decreased MCF-7 cell growth and ERK phosphorylation.
• IGF-2-induced cell survival to 4-OH Tamoxifen was not affected by the reduction of PTP1B or TC-PTP.
• IGF-2-stimulated MCF-7 cell migration was substantially impaired by the downregulation of either PTP1B or TC-PTP, irrespective of ERK pathway activity.

Conclusions:

• PTP1B and TC-PTP play distinct roles in breast cancer cell behavior, particularly in IGF-2-induced migration.
• The anti-migratory effect mediated by PTP1B and TC-PTP downregulation is independent of the ERK pathway.
• These findings highlight PTP1B and TC-PTP as promising therapeutic targets for breast cancer treatment, especially for managing cell migration.